Tourmaline Bio Performance
| TRMLDelisted Stock | 47.98 0.00 0.00% |
The entity has a beta of -0.65, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Tourmaline Bio are expected to decrease at a much lower rate. During the bear market, Tourmaline Bio is likely to outperform the market. Tourmaline Bio right now has a risk of 0.0%. Please validate Tourmaline Bio treynor ratio, semi variance, as well as the relationship between the Semi Variance and day median price , to decide if Tourmaline Bio will be following its existing price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Tourmaline Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent primary indicators, Tourmaline Bio is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors. ...more
| Begin Period Cash Flow | 141 M | |
| Total Cashflows From Investing Activities | -194.3 M |
Tourmaline |
Tourmaline Bio Relative Risk vs. Return Landscape
If you would invest 4,798 in Tourmaline Bio on November 5, 2025 and sell it today you would earn a total of 0.00 from holding Tourmaline Bio or generate 0.0% return on investment over 90 days. Tourmaline Bio is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Tourmaline, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Tourmaline Bio Target Price Odds to finish over Current Price
The tendency of Tourmaline Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 47.98 | 90 days | 47.98 | about 19.52 |
Based on a normal probability distribution, the odds of Tourmaline Bio to move above the current price in 90 days from now is about 19.52 (This Tourmaline Bio probability density function shows the probability of Tourmaline Stock to fall within a particular range of prices over 90 days) .
Tourmaline Bio Price Density |
| Price |
Predictive Modules for Tourmaline Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tourmaline Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Tourmaline Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Tourmaline Bio is not an exception. The market had few large corrections towards the Tourmaline Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tourmaline Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tourmaline Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.32 | |
β | Beta against Dow Jones | -0.65 | |
σ | Overall volatility | 12.41 | |
Ir | Information ratio | 0.17 |
Tourmaline Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tourmaline Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tourmaline Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tourmaline Bio is not yet fully synchronised with the market data | |
| Tourmaline Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (73.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tourmaline Bio generates negative cash flow from operations | |
| Over 89.0% of the company shares are owned by institutional investors |
Tourmaline Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tourmaline Stock often depends not only on the future outlook of the current and potential Tourmaline Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tourmaline Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25.3 M | |
| Cash And Short Term Investments | 258.3 M |
Tourmaline Bio Fundamentals Growth
Tourmaline Stock prices reflect investors' perceptions of the future prospects and financial health of Tourmaline Bio, and Tourmaline Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tourmaline Stock performance.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.21 | |||
| Current Valuation | 993.63 M | |||
| Shares Outstanding | 25.69 M | |||
| Price To Book | 4.75 X | |||
| EBITDA | (89.73 M) | |||
| Total Debt | 244 K | |||
| Book Value Per Share | 10.09 X | |||
| Cash Flow From Operations | (77.26 M) | |||
| Earnings Per Share | (3.44) X | |||
| Total Asset | 309 M | |||
| Retained Earnings | (135.26 M) | |||
About Tourmaline Bio Performance
By examining Tourmaline Bio's fundamental ratios, stakeholders can obtain critical insights into Tourmaline Bio's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Tourmaline Bio is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Things to note about Tourmaline Bio performance evaluation
Checking the ongoing alerts about Tourmaline Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tourmaline Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tourmaline Bio is not yet fully synchronised with the market data | |
| Tourmaline Bio has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (73.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tourmaline Bio generates negative cash flow from operations | |
| Over 89.0% of the company shares are owned by institutional investors |
- Analyzing Tourmaline Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tourmaline Bio's stock is overvalued or undervalued compared to its peers.
- Examining Tourmaline Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tourmaline Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tourmaline Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tourmaline Bio's stock. These opinions can provide insight into Tourmaline Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Tourmaline Stock
If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |